Skip to main content
  • Français
    • Nederlands
    • English

Home
  • Sign In
  • Domaines thérapeutiques
    • Cardiologie
      • ASCVD
      • Insuffisance Cardiaque
    • Dermatologie
      • Urticaire
    • Hématologie
      • PTI
    • Neurologie
      • Sclérose en plaques
    • Oncologie
      • Cancer du sein
      • Prostate Cancer (mCRPC)
      • Mélanome
    • Ophtalmologie
      • Maladies de la rétine
    • Respiratoire
    • Rhumatologie
  • Congrès et évenements
    • Cardiologie
      • BSC
      • ESC
    • Dermatologie
      • EADV
      • Sharing is Caring
    • Hématologie
      • ASH
      • EHA
      • ESH
    • Neurologie
      • CMSC
      • EAN
      • ECTRIMS
    • Oncologie
      • ASCO
      • EBCC
      • ESMO
      • SABCS
    • Rhumatologie
      • Sharing is Caring
  • Contactez-nous

Popular Search

  • improved
  • improving
  • aimovig
  • migration
  • migraine

Recent News

Page protected by password
Netelroos - Doe the test
Behandelingen Netelroos
Search
  • Mechanism of Action

    TPO is the main cytokine involved in regulation of megakaryopoiesis and platelet production, and is the endogenous ligand for the TPO-R.
    Twitter Linkedin Facebook Pinterest Google plus
  • Patient Resources

    Twitter Linkedin Facebook Pinterest Google plus
  • Mechanism of Action - Entresto

    Sacubitril/valsartan, a first-in-class ARNI, delivers simultaneous inhibition of neprilysin and blockade of the AT1 receptor. Sacubitril/valsartan is a sodium salt complex comprising sacubitril (AHU377), a prodrug, which is further metabolized to the...

    Twitter Linkedin Facebook Pinterest Google plus
  • Cosentyx zelf-injectie gids

      Download Dutch version     .field-name-field-np4-expiry-date {display:none;}
  • Guide d'autoinjection du Cosentyx

      Download French version     .field-name-field-np4-expiry-date {display:none;}
  • Indications - Entresto

    ENTRESTO ® is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction. ENTRESTO is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic...

    Twitter Linkedin Facebook Pinterest Google plus
  • Patient Resources - Entresto

    Together for Better In the fight against heart failure condition, we work our hardest every day to develop innovative and effective medication to sustain a better life, keeping the patient in mind. We are aware that the result of...

    Twitter Linkedin Facebook Pinterest Google plus
  • ENTRESTO®: Medication Diary ( French)

    This booklet has been developed to help patients to manage heart failure better monitored and managed.     To receive by post, click on the "Add to card" button below .field-name-field-np4-expiry-date {display:none;}
  • ENTRESTO®: Medication Diary ( Dutch)

    This booklet has been developed to help patients to manage heart failure better monitored and managed.     .field-name-field-np4-expiry-date {display:none;} To receive by post, click on the "Add to card" button below
  • Indications

    Twitter Linkedin Facebook Pinterest Google plus
  • previous
page 

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
 of  18
  • next

Filter by spécialité:

S’abonner à Novartis

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Plan du site
Cookie Settings
©2025 Novartis Belgique & Luxembourg
  • Conditions d'utilisation
  • Politique de protection des données personnelles
  • Cookies
Ce site Internet s’adresse aux professionnels de la santé basés en Belgique & Luxembourg